Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ASTRAZENECA PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-23
TEVA PHARMA
Dec-13
ASTRAZENECA PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3,6203,479-   
Low Rs2,4383,022-   
Sales per share (Unadj.) Rs401.21,996.4-  
Earnings per share (Unadj.) Rs39.7124.7-  
Cash flow per share (Unadj.) Rs46.2286.1-  
Dividends per share (Unadj.) Rs16.00109.18-  
Avg Dividend yield %0.53.4 15.7%  
Book value per share (Unadj.) Rs234.42,217.6-  
Shares outstanding (eoy) m25.00848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.51.6 463.7%   
Avg P/E ratio x76.326.1 292.6%  
P/CF ratio (eoy) x65.511.4 576.8%  
Price / Book Value ratio x12.91.5 881.4%  
Dividend payout %40.387.5 46.0%   
Avg Mkt Cap Rs m75,7182,756,220 2.7%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m2,5910-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m10,0301,692,969 0.6%  
Other income Rs m2610-   
Total revenues Rs m10,2911,692,969 0.6%   
Gross profit Rs m1,249463,620 0.3%  
Depreciation Rs m163136,844 0.1%   
Interest Rs m633,253 0.0%   
Profit before tax Rs m1,341293,523 0.5%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m348-3,584 -9.7%   
Profit after tax Rs m993105,758 0.9%  
Gross profit margin %12.527.4 45.5%  
Effective tax rate %26.0-1.2 -2,126.2%   
Net profit margin %9.96.2 158.5%  
BALANCE SHEET DATA
Current assets Rs m9,3591,143,425 0.8%   
Current liabilities Rs m4,844997,163 0.5%   
Net working cap to sales %45.08.6 521.1%  
Current ratio x1.91.1 168.5%  
Inventory Days Days4991 54.5%  
Debtors Days Days3996 40.8%  
Net fixed assets Rs m2,061552,961 0.4%   
Share capital Rs m504,167 1.2%   
"Free" reserves Rs m5,8110-   
Net worth Rs m5,8611,880,567 0.3%   
Long term debt Rs m0865,653 0.0%   
Total assets Rs m11,4213,868,976 0.3%  
Interest coverage x213.99.8 2,176.2%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.90.4 200.7%   
Return on assets %8.73.6 243.5%  
Return on equity %16.95.6 301.2%  
Return on capital %23.04.9 466.1%  
Exports to sales %00-   
Imports to sales %37.40-   
Net fx Rs m-3,1350-   
CASH FLOW
From Operations Rs m583269,772 0.2%  
From Investments Rs m181-95,591 -0.2%  
From Financial Activity Rs m-245-323,609 0.1%  
Net Cashflow Rs m519-149,429 -0.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare ASTRAZENECA PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare ASTRAZENECA PHARMA With: NATCO PHARMA  ISHITA DRUGS  CORAL LAB.  LAURUS LABS   SHUKRA PHARMA  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.